• Actemra Treatment Linked to Disease Remission in Systemic JIA, German Registry Shows
  • FDA Approves Subcutaneous Form of Actemra for Active Polyarticular JIA
  • How to Deal with Clumsiness from Juvenile Arthritis
  • Tocilizumab Seen to Benefit Most Systemic JIA Patients in Real-life Setting, Study Shows
  • Enbrel Biosimilar Seeks Approval in Japan to Treat Juvenile Idiopathic Arthritis
  • JA Moms Deserve Our Appreciation This Mother’s Day
  • Arthritis Foundation Launches ‘Let’s Get a Grip on Arthritis’ Campaign to Find a Cure
  • Patient-Centered Outcomes Research Institute Approves $20 Million in New Research Funding
  • How Parents Can Support Their Young Child with Juvenile Arthritis
  • How Juvenile Arthritis Affects Gym Class
  • Four Canadian Provinces Add Erelzi to Their Public Plans to Treat Inflammatory Diseases, Including Juvenile Arthritis
  • When Juvenile Arthritis Becomes Juvenile-onset Arthritis